
Stem Cells Industry Research Report 2024
Description
Stem Cells Industry Research Report 2024
Summary
Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).
According to APO Research, The global Stem Cells market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Stem Cells include Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi-post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen and Takeda (TiGenix), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cells.
The Stem Cells market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Stem Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Osiris Therapeutics
NuVasive
Chiesi Pharmaceuticals
Medi-post
JCR Pharmaceutical
MolMed
Pharmicell
Anterogen
Takeda (TiGenix)
CBR
ViaCord
Esperite
LifeCell
CCBC
VCANBIO
BOYA LIFE
Beike Biotechnology
International Medical
Stem Cells segment by Type
Stem Cell Storage
Stem Cell Pharmaceutical and Treatment
Stem Cells Segment by Application
Diseases of the Central Nervous System
Cardiovascular Disease
Diabetes
Cancer
Genetic Diseases
Autoimmune Disease
Bone and Cartilage Repair
Other
Stem Cells Segment by Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stem Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Stem Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stem Cells.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Stem Cells companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Table of Contents
132 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Stem Cells by Type
- 2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
- 2.2.2 Stem Cell Storage
- 2.2.3 Stem Cell Pharmaceutical and Treatment
- 2.3 Stem Cells by Application
- 2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
- 2.3.2 Diseases of the Central Nervous System
- 2.3.3 Cardiovascular Disease
- 2.3.4 Diabetes
- 2.3.5 Cancer
- 2.3.6 Genetic Diseases
- 2.3.7 Autoimmune Disease
- 2.3.8 Bone and Cartilage Repair
- 2.3.9 Other
- 2.4 Assumptions and Limitations
- 3 Stem Cells Breakdown Data by Type
- 3.1 Global Stem Cells Historic Market Size by Type (2019-2024)
- 3.2 Global Stem Cells Forecasted Market Size by Type (2025-2030)
- 4 Stem Cells Breakdown Data by Application
- 4.1 Global Stem Cells Historic Market Size by Application (2019-2024)
- 4.2 Global Stem Cells Forecasted Market Size by Application (2019-2024)
- 5 Global Growth Trends
- 5.1 Global Stem Cells Market Perspective (2019-2030)
- 5.2 Global Stem Cells Growth Trends by Region
- 5.2.1 Global Stem Cells Market Size by Region: 2019 VS 2023 VS 2030
- 5.2.2 Stem Cells Historic Market Size by Region (2019-2024)
- 5.2.3 Stem Cells Forecasted Market Size by Region (2025-2030)
- 5.3 Stem Cells Market Dynamics
- 5.3.1 Stem Cells Industry Trends
- 5.3.2 Stem Cells Market Drivers
- 5.3.3 Stem Cells Market Challenges
- 5.3.4 Stem Cells Market Restraints
- 6 Market Competitive Landscape by Players
- 6.1 Global Top Stem Cells Players by Revenue
- 6.1.1 Global Top Stem Cells Players by Revenue (2019-2024)
- 6.1.2 Global Stem Cells Revenue Market Share by Players (2019-2024)
- 6.2 Global Stem Cells Industry Players Ranking, 2022 VS 2023 VS 2024
- 6.3 Global Key Players of Stem Cells Head office and Area Served
- 6.4 Global Stem Cells Players, Product Type & Application
- 6.5 Global Stem Cells Players, Date of Enter into This Industry
- 6.6 Global Stem Cells Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
- 7 North America
- 7.1 North America Stem Cells Market Size (2019-2030)
- 7.2 North America Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 7.3 North America Stem Cells Market Size by Country (2019-2024)
- 7.4 North America Stem Cells Market Size by Country (2025-2030)
- 7.5 United States
- 7.6 Canada
- 8 Europe
- 8.1 Europe Stem Cells Market Size (2019-2030)
- 8.2 Europe Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 8.3 Europe Stem Cells Market Size by Country (2019-2024)
- 8.4 Europe Stem Cells Market Size by Country (2025-2030)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Russia
- 8.10 Nordic Countries
- 9 Asia-Pacific
- 9.1 Asia-Pacific Stem Cells Market Size (2019-2030)
- 9.2 Asia-Pacific Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 9.3 Asia-Pacific Stem Cells Market Size by Country (2019-2024)
- 9.4 Asia-Pacific Stem Cells Market Size by Country (2025-2030)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 Southeast Asia
- 9.9 India
- 9.10 Australia
- 10 Latin America
- 10.1 Latin America Stem Cells Market Size (2019-2030)
- 10.2 Latin America Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 10.3 Latin America Stem Cells Market Size by Country (2019-2024)
- 10.4 Latin America Stem Cells Market Size by Country (2025-2030)
- 10.5 Mexico
- 10.6 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Stem Cells Market Size (2019-2030)
- 11.2 Middle East & Africa Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 11.3 Middle East & Africa Stem Cells Market Size by Country (2019-2024)
- 11.4 Middle East & Africa Stem Cells Market Size by Country (2025-2030)
- 11.5 Turkey
- 11.6 Saudi Arabia
- 11.7 UAE
- 12 Players Profiled
- 12.1 Osiris Therapeutics
- 12.1.1 Osiris Therapeutics Company Information
- 12.1.2 Osiris Therapeutics Business Overview
- 12.1.3 Osiris Therapeutics Revenue in Stem Cells Business (2019-2024)
- 12.1.4 Osiris Therapeutics Stem Cells Product Portfolio
- 12.1.5 Osiris Therapeutics Recent Developments
- 12.2 NuVasive
- 12.2.1 NuVasive Company Information
- 12.2.2 NuVasive Business Overview
- 12.2.3 NuVasive Revenue in Stem Cells Business (2019-2024)
- 12.2.4 NuVasive Stem Cells Product Portfolio
- 12.2.5 NuVasive Recent Developments
- 12.3 Chiesi Pharmaceuticals
- 12.3.1 Chiesi Pharmaceuticals Company Information
- 12.3.2 Chiesi Pharmaceuticals Business Overview
- 12.3.3 Chiesi Pharmaceuticals Revenue in Stem Cells Business (2019-2024)
- 12.3.4 Chiesi Pharmaceuticals Stem Cells Product Portfolio
- 12.3.5 Chiesi Pharmaceuticals Recent Developments
- 12.4 Medi-post
- 12.4.1 Medi-post Company Information
- 12.4.2 Medi-post Business Overview
- 12.4.3 Medi-post Revenue in Stem Cells Business (2019-2024)
- 12.4.4 Medi-post Stem Cells Product Portfolio
- 12.4.5 Medi-post Recent Developments
- 12.5 JCR Pharmaceutical
- 12.5.1 JCR Pharmaceutical Company Information
- 12.5.2 JCR Pharmaceutical Business Overview
- 12.5.3 JCR Pharmaceutical Revenue in Stem Cells Business (2019-2024)
- 12.5.4 JCR Pharmaceutical Stem Cells Product Portfolio
- 12.5.5 JCR Pharmaceutical Recent Developments
- 12.6 MolMed
- 12.6.1 MolMed Company Information
- 12.6.2 MolMed Business Overview
- 12.6.3 MolMed Revenue in Stem Cells Business (2019-2024)
- 12.6.4 MolMed Stem Cells Product Portfolio
- 12.6.5 MolMed Recent Developments
- 12.7 Pharmicell
- 12.7.1 Pharmicell Company Information
- 12.7.2 Pharmicell Business Overview
- 12.7.3 Pharmicell Revenue in Stem Cells Business (2019-2024)
- 12.7.4 Pharmicell Stem Cells Product Portfolio
- 12.7.5 Pharmicell Recent Developments
- 12.8 Anterogen
- 12.8.1 Anterogen Company Information
- 12.8.2 Anterogen Business Overview
- 12.8.3 Anterogen Revenue in Stem Cells Business (2019-2024)
- 12.8.4 Anterogen Stem Cells Product Portfolio
- 12.8.5 Anterogen Recent Developments
- 12.9 Takeda (TiGenix)
- 12.9.1 Takeda (TiGenix) Company Information
- 12.9.2 Takeda (TiGenix) Business Overview
- 12.9.3 Takeda (TiGenix) Revenue in Stem Cells Business (2019-2024)
- 12.9.4 Takeda (TiGenix) Stem Cells Product Portfolio
- 12.9.5 Takeda (TiGenix) Recent Developments
- 12.10 CBR
- 12.10.1 CBR Company Information
- 12.10.2 CBR Business Overview
- 12.10.3 CBR Revenue in Stem Cells Business (2019-2024)
- 12.10.4 CBR Stem Cells Product Portfolio
- 12.10.5 CBR Recent Developments
- 12.11 ViaCord
- 12.11.1 ViaCord Company Information
- 12.11.2 ViaCord Business Overview
- 12.11.3 ViaCord Revenue in Stem Cells Business (2019-2024)
- 12.11.4 ViaCord Stem Cells Product Portfolio
- 12.11.5 ViaCord Recent Developments
- 12.12 Esperite
- 12.12.1 Esperite Company Information
- 12.12.2 Esperite Business Overview
- 12.12.3 Esperite Revenue in Stem Cells Business (2019-2024)
- 12.12.4 Esperite Stem Cells Product Portfolio
- 12.12.5 Esperite Recent Developments
- 12.13 LifeCell
- 12.13.1 LifeCell Company Information
- 12.13.2 LifeCell Business Overview
- 12.13.3 LifeCell Revenue in Stem Cells Business (2019-2024)
- 12.13.4 LifeCell Stem Cells Product Portfolio
- 12.13.5 LifeCell Recent Developments
- 12.14 CCBC
- 12.14.1 CCBC Company Information
- 12.14.2 CCBC Business Overview
- 12.14.3 CCBC Revenue in Stem Cells Business (2019-2024)
- 12.14.4 CCBC Stem Cells Product Portfolio
- 12.14.5 CCBC Recent Developments
- 12.15 VCANBIO
- 12.15.1 VCANBIO Company Information
- 12.15.2 VCANBIO Business Overview
- 12.15.3 VCANBIO Revenue in Stem Cells Business (2019-2024)
- 12.15.4 VCANBIO Stem Cells Product Portfolio
- 12.15.5 VCANBIO Recent Developments
- 12.16 BOYA LIFE
- 12.16.1 BOYA LIFE Company Information
- 12.16.2 BOYA LIFE Business Overview
- 12.16.3 BOYA LIFE Revenue in Stem Cells Business (2019-2024)
- 12.16.4 BOYA LIFE Stem Cells Product Portfolio
- 12.16.5 BOYA LIFE Recent Developments
- 12.17 Beike Biotechnology
- 12.17.1 Beike Biotechnology Company Information
- 12.17.2 Beike Biotechnology Business Overview
- 12.17.3 Beike Biotechnology Revenue in Stem Cells Business (2019-2024)
- 12.17.4 Beike Biotechnology Stem Cells Product Portfolio
- 12.17.5 Beike Biotechnology Recent Developments
- 12.18 International Medical
- 12.18.1 International Medical Company Information
- 12.18.2 International Medical Business Overview
- 12.18.3 International Medical Revenue in Stem Cells Business (2019-2024)
- 12.18.4 International Medical Stem Cells Product Portfolio
- 12.18.5 International Medical Recent Developments
- 13 Report Conclusion
- 14 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.